Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

With more than 71 million people chronically infected, hepatitis C virus (HCV) is one of the leading causes of liver disease and hepatocellular carcinoma. While efficient antiviral therapies have entered clinical standard of care, the development of a protective vaccine is still elusive. Recent stud...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Wrensch, Florian, Crouchet, Emilie, Ligat, Gaetan, Zeisel, Mirjam B., Keck, Zhen-Yong, Foung, Steven K. H., Schuster, Catherine, Baumert, Thomas F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2018
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021501/
https://ncbi.nlm.nih.gov/pubmed/29977246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01436
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak